Thats because the pill form have adverse affects to get the required dose for OA dmoad. Thats why injectable form is being researched in the first place. Do some research, its all there.
- Forums
- ASX - By Stock
- PAR
- Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS
Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-67
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M |
Open | High | Low | Value | Volume |
25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 181098 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 118621 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 118000 | 0.240 |
4 | 27745 | 0.235 |
1 | 25000 | 0.230 |
2 | 6262 | 0.225 |
6 | 48629 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 64601 | 3 |
0.255 | 50000 | 1 |
0.260 | 21333 | 2 |
0.265 | 69367 | 4 |
0.270 | 53000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online